Millipore

Founded in 1954 as an innovator in membrane filtration technology, Millipore became a global leader in laboratory water purification systems and bioprocessing solutions. It was acquired by Merck KGaA Darmstadt Germany in 2010 and merged with Sigma-Aldrich to form the core of "Milliporesigma"—the U.S. life science business of Merck KGaA. Today its legacy lives on within this larger organization as one of the world’s largest suppliers to pharmaceutical R&D and production[1][2][4][5].

As an enabler rather than drug developer, it does not have clinical results or drug pipeline.

Its products are used globally by pharmaceutical companies for drug discovery, development, quality control testing, biomanufacturing processes—including those involving biologics/cell therapies—and academic/government labs[5][6].

The company’s best-known innovations include Milli-Q ultrapure water systems and advanced filtration/membrane technologies.

In its last years before acquisition it had annual revenues exceeding $1 billion[2].

Now part of a group with over €11 billion revenue across all divisions[5].

No clinical pipeline or programs.